Literature DB >> 3084902

Inpatient management protocols to reduce health care costs.

T Wachtel, A W Moulton, J Pezzullo, M Hamolsky.   

Abstract

A group of 12 internists, members of a university-affiliated hospital, designed and implemented protocols for the general inpatient management of four medical problems (chest pain, stroke, pneumonia, and upper gastrointestinal hemorrhage). Hospital charges for the 63 cases were compared with charges generated by 64 controls who had been patients admitted to the same physicians with the same diagnoses during the same period of the preceding year, before the project was begun. A group of nonparticipating internists was similarly evaluated during the two time periods to control for changes in practice patterns extraneous to the intervention. Adjustment was made for inflation (6%) and differences in case mix. The program resulted in a 15% reduction in total average charge generated by the cases. Sizeable reductions were achieved in utilization of EKGs (34.8%), x-rays (15.4%), laboratory testing (20.4%), and drugs (11.4%). Given the prevailing attitude that health care costs are too high and that many services are unnecessary, the benefit of altering physician behavior by using standards established by them for themselves could be substantial, especially with the threat of more restrictive and less sympathetic modes of controlling costs.

Entities:  

Mesh:

Year:  1986        PMID: 3084902     DOI: 10.1177/0272989X8600600208

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  3 in total

1.  Cost-effective diagnostic test sequencing.

Authors:  B Eiseman; R Jones; M McClatchey; B Borlase
Journal:  World J Surg       Date:  1989 May-Jun       Impact factor: 3.352

2.  Practice guidelines to reduce testing in the hospital.

Authors:  T J Wachtel; P O'Sullivan
Journal:  J Gen Intern Med       Date:  1990 Jul-Aug       Impact factor: 5.128

Review 3.  Cost-effective intervention in stroke.

Authors:  D Dunbabin
Journal:  Pharmacoeconomics       Date:  1992-12       Impact factor: 4.981

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.